| A latex D-dimer reliably excludes venous thromboembolism SM Bates, A Grand'Maison, M Johnston, I Naguit, MJ Kovacs, JS Ginsberg Archives of internal medicine 161 (3), 447-453, 2001 | 160 | 2001 |
| Anticoagulant use in patients with chronic renal impairment A Grand’Maison, AF Charest, WH Geerts American journal of cardiovascular drugs 5 (5), 291-305, 2005 | 110 | 2005 |
| Hereditary hemorrhagic telangiectasia A Grand’Maison Cmaj 180 (8), 833-835, 2009 | 51 | 2009 |
| Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population AF Charest, A Grand'Maison, J McDougall, MB Goldstein American journal of kidney diseases 42 (6), 1193-1199, 2003 | 34 | 2003 |
| Common secondary genomic variants associated with advanced epithelioid hemangioendothelioma ND Seligson, A Awasthi, SZ Millis, BK Turpin, CF Meyer, A Grand'Maison, ... JAMA network open 2 (10), e1912416-e1912416, 2019 | 21 | 2019 |
| Establishing a role for environmental toxicant exposure induced epigenetic remodeling in malignant transformation KM Humphrey, S Pandey, J Martin, T Hagoel, A Grand’Maison, JE Ohm Seminars in cancer biology 57, 86-94, 2019 | 19 | 2019 |
| Not Logged In Login A Grand’Maison, SM Bates, M Johnston, S McRae, JS Ginsberg Thromb Haemost 93 (03), 600-604, 2005 | 19 | 2005 |
| Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing GK Dy, MK Nesline, A Papanicolau-Sengos, P DePietro, CM LeVea, ... BMC medical informatics and decision making 19 (1), 14, 2019 | 18 | 2019 |
| Oncologist uptake of comprehensive genomic profile guided targeted therapy MK Nesline, P DePietro, GK Dy, A Early, A Papanicolau-Sengos, ... Oncotarget 10 (45), 4616, 2019 | 18 | 2019 |
| A population-based pharmacokinetic study of enoxaparin in obese patients with acute coronary syndrome. A Grand'Maison, L Endrenyi, SM MacLeod, WH Geerts, J Douketis, ... Blood 98 (11), 43A-43A, 2001 | 4 | 2001 |
| Optimal duration of anticoagulant treatment of venous thromboembolism F Couturaud, A Grand'Maison, C Kearon Presse medicale (Paris, France: 1983) 29 (24), 1379-1385, 2000 | 4 | 2000 |
| Durée optimale du traitement anticoagulant de la maladie thrombo-embolique veineuse F Couturaud, A Grand'Maison, C Kearon La Presse médicale 29 (24), 1379-1385, 2000 | 2 | 2000 |
| Use of the thrombus precursor protein (TpP) to exclude deep vein thrombosis SM Bates, A Grand'Maison, M Johnston, J McGrath, JS Ginsberg THROMBOSIS AND HAEMOSTASIS, 259-259, 1999 | 2 | 1999 |
| Early Observations from Clinical Trial of Intra-arterial Curaxin CBL0137 J Skitzki, I Puzanov, A Grand'Maison, S O'Brien, J Kane III ANNALS OF SURGICAL ONCOLOGY 29 (SUPPL 2), 525-525, 2022 | | 2022 |
| Optimal Treatment of Venous Thromboembolism in the Elderly A Grand Maison, PS Wells CLINICAL GERIATRICS 10, 53-61, 2002 | | 2002 |
| Effect of hormone replacement therapy on the endogenous thrombin potential. A Grand'Maison, J Douketis, SM Bates, M Johnston, I Naguit, JS Ginsberg BLOOD 96 (11), 272A-272A, 2000 | | 2000 |
| Use of an enzyme immunoassay (EIA) for soluble fibrin to exclude the diagnosis of deep vein thrombosis SM Bates, A Grand'Maison, M Johnston, C Robertson, JS Ginsberg THROMBOSIS AND HAEMOSTASIS, 406-407, 1999 | | 1999 |
| A latex D-Dimer reliably excludes venous SM Bates, A Grand'Maison, M Johnston, MJ Kovacs, I Naguit, JS Ginsberg THROMBOSIS AND HAEMOSTASIS, 258-258, 1999 | | 1999 |
| Immune and cancer testis antigen landscape in sarcoma A Grand’Maison, RJ Seager, YH Lee, MK Nesline, JM Conroy, S Pabla | | |
| The Use of Traditional and New Anticoagulants in the Elderly A Grand’Maison, W Geerts | | |
